Pyrimidine derivatives for the treatment of abnormal cell growth

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8722884
APP PUB NO 20110033441A1
SERIAL NO

12095716

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to salts, solvates and substoichiometric solvates of N-[3-[[[2-[(2,3-dihydro-2-oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-N-methylmethanesulfonamide. The invention also provides pharmaceutical compositions comprising such complexes, as well as methods of treating abnormal cell growth by administering the complexes of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PFIZER INC66 HUDSON BOULEVARD EAST ATTN LEGAL PATENT DEPARTMENT CHIEF IP COUNSEL NEW YORK NY 10001-2192

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kath, John Charles La Mesa, US 33 709
La, Greca Susan Old Lyme, US 1 0
Luzzio, Michael Joseph Noank, US 44 642
Patel, Nandini Chaturbhai Providence, US 20 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 13, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00